Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
BridgeBio Pharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | BridgeBio Pharma Inc. | Option exercise | +17,167 | $16.75 | $287,547 |
| Jul 9, 2026 | BridgeBio Pharma Inc. | Open-market sale | −17,167 | $84.00 | $1,442,028 |
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Mar 4, 2026 | BridgeBio Pharma Inc. | Option exercise | +64,921 | $8.45 | $548,582 |
| Mar 4, 2026 | BridgeBio Pharma Inc. | Open-market sale | −64,921 | $64.87 | $4,211,425 |
| Aug 5, 2025 | BridgeBio Pharma Inc. | Option exercise | +17,167 | $16.75 | $287,547 |
| Aug 5, 2025 | BridgeBio Pharma Inc. | Open-market sale | −17,167 | $49.00 | $841,183 |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Apr 14, 2025 | BridgeBio Pharma Inc. | Option exercise | +10,000 | $8.45 | $84,500 |
| Apr 14, 2025 | BridgeBio Pharma Inc. | Open-market sale | −10,000 | $35.00 | $350,000 |
| Apr 1, 2025 | BridgeBio Pharma Inc. | Option exercise | +30,000 | $8.45 | $253,500 |
| Apr 1, 2025 | BridgeBio Pharma Inc. | Open-market sale | −30,000 | $34.05 | $1,021,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.